No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 3.6x · 10Y median 8.2x · 13th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T13:25:45.484Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T13:25:45.484Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T13:25:45.484Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:25:45.484Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:25:45.484Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Braze, Inc. (BRZE) stock was $26.61 as of Oct 5, 2026, 4:00 PM EDT, up 4.68% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -6.3% · 3-year avg -16.6%/yr
Braze, Inc. operates a global customer engagement platform designed to foster meaningful interactions between consumers and brands.
Software - Application · New York City, NY
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Dec 8, 2026
63 days away
EPS Estimate
0.14
Revenue Est.
$229.86M
Last Quarter Results
EPS
$0.19
vs Estimate
$0.16
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BRZE | $3.00B | $26.61 | +4.68% | -6.34% | N/A | N/A | N/A |
| 2AMBA | $2.99B | $68.26 | -0.57% | -18.81% | -14.63% | -0.61% | vs BRZE |
| 3EXTR | $3.05B | $23.33 | +0.91% | +14.91% | +17.56% | +17.53% | vs BRZE |
| 4BELFA | $3.08B | $208.71 | -0.29% | +83.81% | +72.30% | +27.20% | vs BRZE |
| 5AVPT | $3.11B | $14.66 | +4.19% | -2.96% | +12.00% | N/A | vs BRZE |
| 6INTA | $2.88B | $37.38 | +2.44% | -4.93% | +8.55% | N/A | vs BRZE |
41.41
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$227.23M
vs Estimate
$220.27M
Consensus Rating
Based on 20 analysts
Average Price Target
$37.30
+40.2% upside
Low
$30.00
Current
$26.61
High
$50.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.14 | $0.14 | $0.14 | 13 |
| Quarter ending Jan 2027 | $0.19 | $0.21 | $0.22 | 13 |
| Quarter ending Apr 2027 | $0.19 | $0.19 | $0.19 | 9 |
| Quarter ending Jul 2027 | $0.26 | $0.26 | $0.26 | 11 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.63 | $0.64 | $0.65 | 13 |
| FY 2028 | $0.81 | $0.98 | $1.07 | 11 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $229.69M | $229.86M | $230.21M | 13 |
| Quarter ending Jan 2027 | $243.83M | $244.26M | $245.00M | 13 |
| Quarter ending Apr 2027 | $248.29M | $248.86M | $251.49M | 10 |
| Quarter ending Jul 2027 | $263.52M | $264.13M | $266.91M | 12 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Jan 31, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $911.79M | $912.34M | $913.39M | 16 |
| FY 2028 | $1.05B | $1.07B | $1.08B | 15 |
